Singapore markets closed

Takeda Pharmaceutical Company Limited (TKPHF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
28.450.00 (0.00%)
At close: 12:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 45.43B
Enterprise value 74.11B
Trailing P/E 38.30
Forward P/E 24.27
PEG Ratio (5 yr expected) 3.40
Price/sales (ttm)1.63
Price/book (mrq)1.00
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.07

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-13.10%
S&P500 52-week change 329.57%
52-week high 334.47
52-week low 326.25
50-day moving average 328.83
200-day moving average 329.46

Share statistics

Avg vol (3-month) 39.3k
Avg vol (10-day) 321.94k
Shares outstanding 51.57B
Implied shares outstanding 61.6B
Float 81.55B
% held by insiders 10.03%
% held by institutions 142.64%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.39
Forward annual dividend yield 44.88%
Trailing annual dividend rate 3184.00
Trailing annual dividend yield 3646.75%
5-year average dividend yield 44.57
Payout ratio 4163.61%
Dividend date 328 Jun 2010
Ex-dividend date 428 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 4.28%
Operating margin (ttm)9.44%

Management effectiveness

Return on assets (ttm)2.61%
Return on equity (ttm)2.76%

Income statement

Revenue (ttm)4.17T
Revenue per share (ttm)2,670.94
Quarterly revenue growth (yoy)1.30%
Gross profit (ttm)N/A
EBITDA 1.21T
Net income avi to common (ttm)178.22B
Diluted EPS (ttm)0.74
Quarterly earnings growth (yoy)-11.30%

Balance sheet

Total cash (mrq)288.36B
Total cash per share (mrq)183.79
Total debt (mrq)5.21T
Total debt/equity (mrq)77.21%
Current ratio (mrq)1.06
Book value per share (mrq)4,297.21

Cash flow statement

Operating cash flow (ttm)731.45B
Levered free cash flow (ttm)-9.88B